FDA approves omalizumab for food allergy reactions based on NIH research
Moment‘s Food and Drug Administration blessing of a supplemental biologics license for the monoclonal antibody omalizumab( Xolair) highlights the vital part of the National Institutes of Health- supported exploration that underpins the FDA decision. FDA
Read More